SOLV Stock Gains as Q3 Earnings & Sales Beat Estimates, '24 View Up
Solventum's top line reflects the favorable impact of pricing normalization. Organic growth is primarily driven by rising demand for MedSurg products.
Solventum raises annual profit forecast on strong surgical product sales
3M spin-off Solventum raised its annual profit forecast on Thursday, betting on strong sales of its wound care and surgical sterilization products.
Solventum Q3 Earnings Likely to Reflect Declining Volume Trend
SOLV's Q3 performance is likely to have been hurt by below-par revenue growth in several markets, coupled with currency headwinds. Improved pricing might have offset sales decline.
Solventum Taps Bankers to Explore Sale of Filtration Unit
The business is expected to draw takeover interest from private equity and strategic buyers.
Will Solventum (SOLV) Beat Estimates Again in Its Next Earnings Report?
Solventum (SOLV) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
SOLV or MEDP: Which Is the Better Value Stock Right Now?
Investors with an interest in Medical Services stocks have likely encountered both Solventum (SOLV) and Medpace (MEDP). But which of these two stocks presents investors with the better value opportunity right now?
26 Millionaires and Billionaires Can't Be Wrong. The One Stock All of Them Are Buying
Watching what the smart money is buying can be a useful investment strategy.
Solventum Shares May Gain on the Launch of Its New V.A.C Therapy
SOLV announces the launch of its V.A.C. Peel and Place Dressing for providing efficient and effective care in case of negative pressure wound therapy.
Trade Tracker: Jenny Harrington sells Solventum Corp.
Jenny Harrington, CEO Gilman Hill Asset Management, joins CNBC's "Halftime Report" to explain why she's getting out of Solventum.
Solventum's (SOLV) Q2 Earnings Beat Estimates, ' 24 View Raised
Solventum's (SOLV) second-quarter results show resilience in MedSurg and Health Information Systems. Its shrinking margins pose concerns.
Solventum Corporation (SOLV) Q2 2024 Earnings Call Transcript
Solventum Corporation (NYSE:SOLV ) Q2 2024 Earnings Call August 8, 2024 4:30 PM ET Company Participants Kevin Moran - Senior Vice President, Investor Relations Bryan Hanson - Chief Executive Officer Wayde McMillan - Chief Financial Officer Conference Call Participants Travis Steed - Bank of America Vik Chopra - Wells Fargo David Roman - Goldman Sachs Operator Good day. My name is Ellie, and I will be your conference operator for today.
Solventum's second-quarter profit falls 70% on higher expenses
3M spin-off Solventum's second-quarter profit fell more than 70% on Thursday, hurt by limited sales growth of its wound care and surgical sterilization products and higher expenses, as it navigates functioning as a newly independent company.
